In this episode, Dr. Joel Schuman gives a detailed overview of how a team of collaborators from diverse academic backgrounds developed Optical Coherence Tomography (OCT), a technology that was a leap forward in the field of Ophthalmology. Dr. Schuman further explores how curiosity lies at the center of his motivation to continue discovering and innovating even after co-developing a breakthrough medical technology. 

In this episode, Dr. David Pyott shares insights and lessons learned as the former Chairman of the Board and CEO of Allergan. David further details the genesis of The Ophthalmology Foundation, highlighting the importance of education and maintaining a global perspective in order to improve eye care and advance the preservation and restoration of vision for all.

Lex Gillette, five-time Paralympian and 2020 Tokyo silver medalist in long jump, shares his experience from a young boy with sudden vision loss to world-class athlete. Lex gives an overview of his training, the importance of having the right mindset, and how anybody with a vision can do more than most dream is possible.

Jay Newman, Head of U.S. Commercial at Spark Therapeutics provides a detailed overview of gene therapy for inherited retinal disease. Jay discusses the challenges associated with gaining regulatory approval and how this approval has impacted the company and the low vision community at large. 

Dr. Mahadeo Sukhai shares his experience as a visually impaired student who was fast tracked through high school and entered university at age 15, highlighting the numerous challenges and the benefit of a growth mindset. Dr. Sukhai further describes new initiatives in low vision research and shares advice for people who are striving for success in life and work while dealing with a visual impairment.

Ophthalmologist and vision science researcher Dr. Brian Ballios provides an overview of stem cell therapies for inherited retinal diseases, including Retinitis Pigmentosa. Dr. Ballios further discusses the importance of genetic testing, highlighting that knowledge of a patient's underlying mutation is often required to access clinical trials and approved therapies. 

In this episode, Ophthalmology and visual science researcher Dr. Yves Sauvé gives an overview of how vision works in the eye and in the brain, highlighting normal and pathological changes in these structures that can alter the visual experience. Dr. Sauvé further describes modifiable lifestyle factors that can influence vision as we age, as well as various related topics that he covers in depth in his book, "Feeling the Meaning Of Life".

In this episode, Dr. Carlos Quezada Ruiz describes the evolution and challenges of clinical trials from his unique perspective as an active retina specialist who also oversees modules of some of the world’s most impactful clinical trials in Ophthalmology in his role as Senior Medical Director at Genentech. Dr. Quezada Ruiz further highlights the importance of a patient-centric approach for everyone working in the field of Ophthalmology, including industry professionals, basic scientists, and clinicians.

For this episode, Bruno was joined by Dr. Rubens Belfort as a guest editor to have a candid conversation with Dr. Arun Singh. Dr. Singh has more than 250 articles published in peer reviewed journals. He is the editor of British Journal of Ophthalmology, and a manuscript reviewer for 14 national and international journals. We dove into the intricacies of scientific publications, discussing what works, and what can be improved.

http://broadeye.org/singh/

In this episode, Dr. Allan Slomovic provides a high level overview of current and emerging therapies for corneal and ocular surface diseases. Dr. Slomovic further shares stories of mentorship and philanthropy, as well as a very personal experience with COVID-19 as a patient himself.

More information about the guest here.